Loading
A phase 3 trial of liposomal irinotecan, cAPOX (capecitabine, oxaliplatin), tegafur, gimeracil and oteracil (S-1), gemcitabine and other drugs in pancreatic cancer, run by CSPC Ouyi Pharmaceutical Co., Ltd., not yet recruiting.
Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic Cancer is a phase 3, randomised interventional study registered as NCT06571461 by CSPC Ouyi Pharmaceutical Co., Ltd., with a registry enrolment figure of 408 participants, started 2024-09 and due to reach its primary completion in 2028-01. Interventions recorded: Liposomal Irinotecan; Oxaliplatin; S-1; Gemcitabine; Capecitabine. Conditions listed: Pancreatic Cancer. Primary outcome: Disease-free survival (DFS). Pancreatic eligibility wording from the registry: "Histologically confirmed resected ductal pancreatic adenocarcinoma (including adenosquamous carcinoma)". No results are recorded here; the registry entry is the source.
Shares Liposomal irinotecan, CAPOX (capecitabine, oxaliplatin), Resectable pancreatic ductal adenocarcinoma, Topoisomerase-I inhibitors (and ADC payloads) and the tag pancreatic-deep-dive.
Shares Tegafur, gimeracil and oteracil (S-1), Liposomal irinotecan, CAPOX (capecitabine, oxaliplatin), Resectable pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Liposomal irinotecan, CAPOX (capecitabine, oxaliplatin), Resectable pancreatic ductal adenocarcinoma, Topoisomerase-I inhibitors (and ADC payloads) and the tag pancreatic-deep-dive.
Shares Liposomal irinotecan, CAPOX (capecitabine, oxaliplatin), Topoisomerase-I inhibitors (and ADC payloads), Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Liposomal irinotecan, CAPOX (capecitabine, oxaliplatin), Resectable pancreatic ductal adenocarcinoma, Topoisomerase-I inhibitors (and ADC payloads) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Topoisomerase-I inhibitors (and ADC payloads), Capecitabine, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Capecitabine, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine and the tag pancreatic-deep-dive.
Shares Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine, Cytotoxic chemotherapy and the tag pancreatic-deep-dive.